Blood Test News and Research

RSS

Study determines the diagnostic utility of liver stiffness measurement

Even after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in advanced liver disease. In cooperation with researchers from Spain, a research team led by Georg Semmler and Mattias Mandorfer from the Division of Gastroenterology and Hepatology at MedUni Vienna's Department of Medicine III showed that the non-invasive tests explored in their earlier studies accurately estimate the probability of sequelae.

3 Nov 2022

Study elucidates mechanism that is crucial for making hemophilia therapy effective

Hemophilia A is the most common severe form of hemophilia. It affects almost exclusively males. The disease can usually be treated well, but not for all sufferers.

27 Oct 2022

Applications of artificial intelligence in COVID-19 clinical response measures

Researchers reviewed existing literature on the use of AI in health care, to characterize the AI applications used in clinical applications during the COVID-19 pandemic, investigate the location, timing, and extent of AI use in healthcare, and examine the U.S. regulatory approval processes.

25 Oct 2022

Blood test uses artificial intelligence and biomarkers to prenatally detect fetal congenital heart defects

Researchers at Beaumont Hospital, Royal Oak, have discovered a blood test for pregnant women that uses artificial intelligence and genetic-related biomarkers to accurately detect, fetal congenital heart defects, well before birth.

18 Oct 2022

Research proposes a set of conditions that could be the starting point for ulcerative colitis

Ulcerative colitis is the most common type of inflammatory bowel disease, characterised by chronic ulcers and inflammation in the colon and rectum.

18 Oct 2022

Cell-free DNA circulating in the blood may signal early signs of dementia and frailty

In a long-term prospective study of more than 600 older participants, Johns Hopkins Medicine researchers say they have evidence that higher levels of cell-free DNA circulating in the blood may signal increased risk of chronic inflammation associated with early signs of frailty and dementia.

11 Oct 2022

AI model could be used to enable more effective care for skin cancer patients

The artificial intelligence model could be utilized to enable more effective care for skin cancer patients and could lead to similar breakthroughs in the diagnosis and treatment of other cancers.

7 Oct 2022

Study identifies a potential biological marker to help diagnose postpartum depression

A federally funded study led by Johns Hopkins Medicine researchers discovered that communication among cells is altered in pregnant women who go on to develop postpartum depression (PPD) after giving birth.

4 Oct 2022

Daxor's BVA-100 diagnostic blood test reduces hospital length of stay for heart failure patients

Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company's BVA-100 diagnostic blood test in reducing hospital length of stay (LOS) for heart failure (HF) patients.

3 Oct 2022

New data validates the benefits of Daxor's BVA-100 blood test for heart failure patients

Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company's BVA-100 blood test for heart failure patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought together the world's leading experts in heart failure from September 30th thru October 3rd, 2022, in Washington, DC.

3 Oct 2022

Blood test could predict people's likelihood of developing long Covid

A blood test taken at the time of Covid-19 infection could predict who is most likely to develop long Covid, suggests a new small-scale study led by UCL researchers.

28 Sep 2022

Consumption of highly refined fiber may increase liver cancer risk in some people

Many people commonly consume fiber-enriched foods to promote weight loss and prevent chronic diseases such as diabetes and cancer.

26 Sep 2022

New genomic test can predict a patient's risk of developing severe COVID-19, research suggests

A genomic test being developed by a Charlottesville, Va., company can predict a patient's risk of developing severe COVID-19, new research from UVA Health suggests.

16 Sep 2022

Final results of the PATHFINDER study by GRAIL on multi-cancer early detection tests announced

A new press release announced the results of their interventional PATHFINDER study on the early detection of cancer using multi-cancer early detection (MCED) blood tests.

13 Sep 2022

Novel tests detect common cancer signals across over 50 types of cancer

Cancer doctors, care providers and payers need to get ready for a major shift in early cancer detection that will affect almost every stage of cancer diagnosis and treatment. New data supporting the accuracy of multi-cancer early detection (MCED) blood testing (1), presented at the ESMO Congress 2022, have major implications for future cancer care provision, said Fabrice André, ESMO 2022 Scientific Co-Chair.

12 Sep 2022

New technology can capture stray ovarian cancer cells from a simple blood test

A new type of technology can capture stray ovarian cancer cells from a simple blood test and successfully predict cancer in people who have a lesion or cyst in the pelvic region, according to a new study by a Wilmot Cancer Institute physician/scientist.

9 Sep 2022

UT Southwestern scientists identify genetic mutations that contribute to nonalcoholic fatty liver disease

Using a genetic screening platform developed by a UT Southwestern Nobel Laureate, scientists with the Center for the Genetics of Host Defense at UT Southwestern Medical Center have identified genetic mutations that contribute to nonalcoholic fatty liver disease (NAFLD), providing a potential future target for therapeutic interventions.